Literature DB >> 18092268

Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement.

N C de Oliveira1, L M dos Santos Sabbag, L M Ueno, R B C de Souza, C L Borges, A L de Sá Pinto, F R Lima.   

Abstract

OBJECTIVE: To evaluate the exercise capacity of women with systemic sclerosis (SSc) without pulmonary involvement using a cardiopulmonary stress test.
METHODS: Thirteen consecutive female SSc patients [mean age 40.8+/-14 years, mean body mass index (BMI) 25.5+/-3.7 kg/m2] without pulmonary and cardiac involvement and 13 healthy sedentary female controls (mean age 41.6+/-9.1 years, mean BMI 23.7+/-3.8 kg/m2) matched by age and BMI underwent a maximum cardiopulmonary stress test (Bruce protocol). The following parameters were analysed: peak oxygen uptake (VO2peak), anaerobic threshold (AT), respiratory compensation point (RCP) and metabolic equivalent (MET) of the VO2peak. Comparisons between groups were analysed using the Student t-test.
RESULTS: Forced vital capacity (FVC; 92.2+/-14.2% predicted) and carbon monoxide diffusion lung capacity (DL CO; 85.8+/-5.8% predicted) were within the normal range in SSc patients. VO2peak of SSc patients was significantly reduced in comparison to the control group (19.8+/-4.6 vs. 23.7+/-4.5 mL/kg/min, p = 0.04). SSc patients also had a significant reduction in MET at peak exercise (5.6+/-1.3 vs. 6.7+/-1.3 MET, p = 0.04) and a significant shorter time interval between AT and RCP compared to the control group (112.6+/-95.6 vs. 164.0+/-65.3 s, p = 0.03).
CONCLUSION: SSc patients without pulmonary impairment have reduced exercise capacity. Abnormal vascular response to exercise may account for this finding, as the vascular system is one of the major target organs in this pathological condition.

Entities:  

Mesh:

Year:  2007        PMID: 18092268     DOI: 10.1080/03009740701605889

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  9 in total

1.  Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.

Authors:  Beth Wallace; Suzanne Kafaja; Daniel E Furst; Veronica J Berrocal; Peter A Merkel; James R Seibold; Maureen D Mayes; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2015-02-09       Impact factor: 7.580

Review 2.  Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation.

Authors:  Fabiana B Benatti; Bente K Pedersen
Journal:  Nat Rev Rheumatol       Date:  2014-11-25       Impact factor: 20.543

3.  Exercise-induced brachial artery blood flow and vascular function is impaired in systemic sclerosis.

Authors:  Daniel R Machin; Heather L Clifton; Ryan S Garten; Jayson R Gifford; Russell S Richardson; D Walter Wray; Tracy M Frech; Anthony J Donato
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-30       Impact factor: 4.733

4.  High-intensity interval training can improve hand grip strength, inspiratory muscle, and quality of life in systemic sclerosis subjects.

Authors:  Irma Ruslina Defi; Chandrawati Gultom; Maria Jessica Chorman; Jennie Jennie
Journal:  Reumatologia       Date:  2021-04-27

5.  Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed.

Authors:  Christopher P Denton; Jerome Avouac; Frank Behrens; Daniel E Furst; Ivan Foeldvari; Marc Humbert; Doerte Huscher; Otylia Kowal-Bielecka; Marco Matucci-Cerinic; Peter Nash; Christian F Opitz; David Pittrow; Lewis J Rubin; James R Seibold; Oliver Distler
Journal:  Arthritis Res Ther       Date:  2011-06-20       Impact factor: 5.156

6.  Assessment of cardiac autonomic nervous system involvement in systemic sclerosis via exercise heart rate recovery.

Authors:  Ugur Nadir Karakulak; Sercan Okutucu; Levent Şahiner; Naresh Maharjan; Elifcan Aladag; Ali Akdogan; Levent Kilic; Ergun Baris Kaya; Kudret Aytemir; Lale Tokgozoglu
Journal:  Med Princ Pract       Date:  2014-11-22       Impact factor: 1.927

7.  Tetrahydrobiopterin Administration Augments Exercise-Induced Hyperemia and Endothelial Function in Patients With Systemic Sclerosis.

Authors:  Daniel R Machin; Heather L Clifton; D Walter Wray; Tracy M Frech; Anthony J Donato
Journal:  Front Med (Lausanne)       Date:  2022-01-10

8.  Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia.

Authors:  Fujiko Someya; Naoki Mugii
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2013-01-22

9.  Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis.

Authors:  Ralf Ewert; Till Ittermann; Dirk Habedank; Matthias Held; Tobias J Lange; Michael Halank; Jörg Winkler; Sven Gläser; Horst Olschewski; Gabor Kovacs
Journal:  BMC Pulm Med       Date:  2019-11-29       Impact factor: 3.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.